Jun 20, 2024
1:25
For every 25 shares held, investors received 1.
The split itself did not change the total investment value.
Atara Biotherapeutics, Inc. (GETTEX:AT20) operates in the Pharmaceuticals: major industry.
Atara Biotherapeutics, Inc. company overviewAtara Biotherapeutics, Inc.'s most recent stock split was on June 20, 2024. It was a 1-for-25 reverse split, so shareholders received 1 share for every 25 they held.
Atara Biotherapeutics, Inc. has split its stock once. This history records one reverse split, on June 20, 2024.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Atara Biotherapeutics, Inc.'s 1-for-25 reverse split on June 20, 2024, every 25 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Atara Biotherapeutics, Inc. has not announced a new split in our records. Its most recent split was on June 20, 2024, 2 years ago. Companies announce splits in advance, and any new GETTEX:AT20 split will appear on this page.